61 related articles for article (PubMed ID: 38430428)
1. Long-term survival outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of hepatocellular carcinoma patients.
Yan G; Zhang K; Yan L; Zhang Y
World J Surg Oncol; 2024 May; 22(1):144. PubMed ID: 38822337
[TBL] [Abstract][Full Text] [Related]
2. Repeat cytoreduction with Hyperthermic Intraperitoneal chemotherapy in patients with peritoneal disease: A 5-year retrospective analysis.
Mendes J; Marques S; Peyroteo M; Lobo M; Sousa F; Fernandes M; Videira JF; de Sousa A
Surg Oncol; 2024 Jun; 54():102078. PubMed ID: 38640857
[TBL] [Abstract][Full Text] [Related]
3. [Safety of patients undergoing radical resection combined with paclitaxel-based hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer].
Mei JX; Zhao LY; Zhang WH; Liu K; Chen XL; Yang K; Hu JK
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):471-477. PubMed ID: 38778687
[No Abstract] [Full Text] [Related]
4. Important Predictive Factors for the Prognosis of Patients With Peritoneal Metastasis of Gastric Cancer.
Torun BC; Sobutay E; Akbulut OE; Saglam S; Yilmaz S; Yonemura Y; Canbay E
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38806761
[TBL] [Abstract][Full Text] [Related]
5. Review of management and treatment of peritoneal metastases from gastric cancer origin.
Manzanedo I; Pereira F; Serrano Á; Pérez-Viejo E
J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S20-S29. PubMed ID: 33968423
[TBL] [Abstract][Full Text] [Related]
6. Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Alyami M; Mercier F; Siebert M; Bonnot PE; Laplace N; Villeneuve L; Passot G; Glehen O; Bakrin N; Kepenekian V
Eur J Surg Oncol; 2021 Jan; 47(1):128-133. PubMed ID: 31253545
[TBL] [Abstract][Full Text] [Related]
7. Initial Experience Using Laparoscopic HIPEC for Gastric Cancer with Peritoneal Metastasis: Safety and Outcomes.
Read MD; Drake J; Hashemipour G; Powers BD; Mehta R; Sinnamon A; Pimiento JM; Dineen SP
Ann Surg Oncol; 2024 Jun; 31(6):3750-3757. PubMed ID: 38430428
[TBL] [Abstract][Full Text] [Related]
8. Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer.
Canbay E; Canbay Torun B; Cosarcan K; Altunal C; Gurbuz B; Bilgic C; Sezgin C; Kaban KK; Yilmaz S; Yazici Z
J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S47-S56. PubMed ID: 33968425
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Oncological Outcomes and Long-Term Survival among Patients with Gastric Cancer and Limited Peritoneal Disease Progression after Neoadjuvant Chemotherapy.
Kobiałka S; Sędłak K; Pelc Z; Mlak R; Endo Y; Bogacz P; Kurylcio A; Polkowski WP; Pawlik TM; Rawicz-Pruszyński K
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202168
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
11. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with improved perioperative outcomes: a single-center early experience propensity-matched analysis.
Shaltiel T; Solomon D; Pletcher ER; Golas BJ; Magge DR; Sarpel U; Labow DM; Cohen NA
Surg Endosc; 2022 Aug; 36(8):6153-6161. PubMed ID: 35080674
[TBL] [Abstract][Full Text] [Related]
12. Short and long-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal cancer peritoneal metastasis: Propensity score-matched comparison between laparoscopy vs. open approaches.
Chang SC; Fingerhut A; Chen WT
Surg Oncol; 2022 Aug; 43():101766. PubMed ID: 35430126
[TBL] [Abstract][Full Text] [Related]
13. Overview of Chemotherapy for Gastric Cancer.
Sato Y; Okamoto K; Kida Y; Mitsui Y; Kawano Y; Sogabe M; Miyamoto H; Takayama T
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835872
[TBL] [Abstract][Full Text] [Related]
14. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Ajani JA; D'Amico TA; Bentrem DJ; Chao J; Cooke D; Corvera C; Das P; Enzinger PC; Enzler T; Fanta P; Farjah F; Gerdes H; Gibson MK; Hochwald S; Hofstetter WL; Ilson DH; Keswani RN; Kim S; Kleinberg LR; Klempner SJ; Lacy J; Ly QP; Matkowskyj KA; McNamara M; Mulcahy MF; Outlaw D; Park H; Perry KA; Pimiento J; Poultsides GA; Reznik S; Roses RE; Strong VE; Su S; Wang HL; Wiesner G; Willett CG; Yakoub D; Yoon H; McMillian N; Pluchino LA
J Natl Compr Canc Netw; 2022 Feb; 20(2):167-192. PubMed ID: 35130500
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic Heated Intraperitoneal Chemotherapy in the Treatment of Carcinomatosis of Gastric Adenocarcinoma Origin.
White MG; Badgwell BD
J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682880
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
